peroxynitrous acid has been researched along with fumonisin b1 in 1 studies
| Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) | Studies (fumonisin b1) | Trials (fumonisin b1) | Recent Studies (post-2010) (fumonisin b1) |
|---|---|---|---|---|---|
| 3,303 | 21 | 1,230 | 1,484 | 14 | 454 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bramanti, P; Crisafulli, C; Cuzzocrea, S; Di Paola, R; Esposito, E; Genovese, T; Mazzon, E; Salvemini, D | 1 |
1 other study(ies) available for peroxynitrous acid and fumonisin b1
| Article | Year |
|---|---|
Anti-inflammatory and anti-apoptotic effects of fumonisin B1, an inhibitor of ceramide synthase, in a rodent model of splanchnic ischemia and reperfusion injury.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; bcl-2-Associated X Protein; Ceramides; Disease Models, Animal; Enzyme Inhibitors; Fas Ligand Protein; Fumonisins; In Situ Nick-End Labeling; Male; Mesenteric Vascular Occlusion; Oxidative Stress; Oxidoreductases; Peroxynitrous Acid; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2008 |